De Gennes J L, Truffert J, Colas-Belcourt J F
Ann Med Interne (Paris). 1975 Jan;126(1):19-26.
The demonstration in certain sera by electrophoresis an Agar gel, according to Noble's technique, of a further band of intermediate pre-betalipoprotein, between the betalipoproteins and the usual rapid pre-betalipoproteins, led to the designation of this fraction under the name of slow pre-betalipoprotein or pre-beta-lipoprotein. To the rare studies so far published on this subject, we bring here our contribution in the form of a routine analysis of the variations, and not only the presence, but also the relative concentration of the slow pre-beta-lipoproteins with regard to the rapid prebetalipoproteins. On the fasting serum, after 12 hours fasting, comparative studies of normal control subjects (104 cases) of essential hypercholesterolemia, with or without tendinous xanthomas, corresponding to type IIa (110 cases), mixed hyperlipidemia of type II + IV or III, on paper electrophoresis, corresponds usually to type IIb (204 cases) and, finally, massive endogenous hypertriglyceridemia, corresponding to type IV (95 cases). These indicate clearly the elective concentration of the band of slow pre-betalipoproteins persisting after 12 hours fasting in cases of mixed hyperlipidemia (73% of cases), whilst it is rare in the other groups (no more than 5% of cases). A more complete study of 204 cases of mixed hyperlipidemia showed that the high frequency of slow pre-betalipoproteins is situated in a fairly narrow range of relatively moderate hypertriglyceridemia, between the lower limit of 1.50 and the upper limit of 6 to 7 g/l: the maximum frequency and intensity is situated within the area of 2.50 to 4 g/l. The cases who have already had cardiovascular accidents are more often found to have this band than the cases without complications in a fairly similar age group. However, longitudinal studies, both midterm in relation to therapeutic correction, and short term throughout the day or between the 8th and 12th hour of fasting, have clearly revealed the potential labile nature of this fraction, and show the pathological nature of its sometimes massive persistence beyond the 8th hour and even beyond the 12th hour of fasting. This is a sign of pathological blocking of its transformation rather than of a constitutional lipoprotein abnormality.
根据诺布尔技术,在琼脂凝胶上通过电泳在某些血清中显示出一条介于β脂蛋白和常见快速前β脂蛋白之间的中间前β脂蛋白的额外条带,这导致该部分被命名为慢速前β脂蛋白或前β-脂蛋白。对于迄今为止关于该主题发表的罕见研究,我们在此以常规分析变化的形式做出贡献,不仅分析慢速前β脂蛋白的存在情况,还分析其相对于快速前β脂蛋白的相对浓度。在空腹12小时后的空腹血清中,对正常对照受试者(104例)、患有或不患有肌腱黄色瘤的原发性高胆固醇血症患者(对应IIa型,110例)、II + IV型或III型混合高脂血症患者(在纸上电泳通常对应IIb型,204例)以及最后大量内源性高甘油三酯血症患者(对应IV型,95例)进行了比较研究。这些研究清楚地表明,在混合高脂血症病例(73%的病例)中,空腹12小时后仍存在慢速前β脂蛋白条带的选择性浓度,而在其他组中则很少见(不超过5%的病例)。对204例混合高脂血症患者进行的更全面研究表明,慢速前β脂蛋白的高频率出现在相对中等高甘油三酯血症的相当窄的范围内,下限为1.50,上限为6至7 g/l:最大频率和强度出现在2.50至4 g/l的区域内。在年龄相当的相似组中,已经发生心血管意外的病例比没有并发症的病例更常出现这条带。然而,与治疗纠正相关的中期纵向研究以及全天或空腹第8至12小时之间的短期纵向研究清楚地揭示了该部分潜在的不稳定性质,并表明其有时在空腹第8小时甚至第12小时后大量持续存在的病理性质。这是其转化的病理阻滞的迹象,而不是先天性脂蛋白异常的迹象。